Free Daily Podcast Summary
Blood Podcast: Daily Summaries Delivered
by American Society of Hematology
Stay up to date on the latest research and reviews for both clinical and basic hematology with Blood podcast, published weekly in conjunction with each issue of Blood. Additionally, Blood review series podcasts feature in depth discussion with authors of recently published review articles.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- Yesterday30 min
Prothrombotic FVIII Mutation and Prime Editing T-Cells for Drug Resistance
In this week's episode, Blood editor Dr. Natalie Rosen interviews Dr. Lindsey George, Director of Clinical In Vivo Gene Therapy and an attending physician in the Division of Hematology at Children's Hospital of Philadelphia, and also Dr. Miles Horton and Dr. Thomas Lew of the Royal Melbourne Hospital and Peter McCallum Cancer Center, and the Walter and Eliza Hall Institute of Medical Research on their latest articles published in Blood on the characterization of the prothrombotic mechanisms of recombinant FVIII Aurora and turning immunosuppressants into tools for bidirectional in vivo control. Dr. George discusses "Factor VIII Aurora: a naturally occurring gain-of-function FVIII variant with enhanced FIXa affinity" and Drs. Horton and Lew discuss "Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression".
- 1 weeks ago29 min
Triple threat for BPDCN and Human Milk Oligosaccharides after HSCT
In this week's episode, Blood editor Dr. Laurie Sehn interviews Dr. Andrew Lane from the Dana-Farber Cancer Institute and Dr. Pooja Khandelwal from the Cincinnati Children's Hospital Medical Center on their latest articles published in Blood on new drug combinations for BPDCN and reduced intestinal dysbiosis after HSCT. Dr. Lane discusses "Tagraxofusp, azacitidine, and venetoclax for blastic plasmacytoid dendritic cell neoplasm" and after, Dr. Khandelwal discusses "Human milk oligosaccharide (2′-FL) modifies the gut microbiome in children after bone marrow transplant".
- 2 weeks ago13 min
Restoring Stem Cell Function After Iron Overload
In this week's episode, Blood editor Dr. Laurie Sehn interviews Dr. Annamaria Aprile of the San Raffaele Telethon Institute for Gene Therapy on her latest article published in Blood titled "Iron overload damages mitochondria and induces metabolic rewiring of hematopoietic stem cells toward glycolysis." Dr. Aprile describes how reducing iron and mitochondrial reactive oxygen species in vivo restores mitochondrial activity, quiescence, and the self-renewal of HSCs. She discusses the therapeutic implications of these findings, focusing on combining iron chelation with a mitochondrial-focused antioxidant to protect or restore stem cell function, a strategy that still needs further testing, including in patient-derived cells.
- 3 weeks ago16 min
Venetoclax combinations in untreated CLL and the Clinical Significance of Clonal Monocytosis
In this week's episode, Blood editor Dr. Laura Michaelis interviews Dr. Moritz Fürstenau of University Hospital Cologne and Dr. William Dunn of the University of Cambridge on their latest articles published in Blood on CLL and clonal monocytosis. Dr. Fürstenau discusses "Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial" highlighting greater improvements in patient-reported quality of life. Dr. Dunn discusses "The prevalence and clinical significance of clonal monocytosis" describing how using sex-specific monocyte thresholds and excluding isolated DNMT3A mutations refines the association between CMUS and MN.
- 4 weeks ago27 min
New Perspectives on Anticoagulation and Hyperinflammation
In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Dan Chalothorn and David Gutstein from Regeneron Pharmaceuticals, and Dr. Ajitha Thanabalasuriar from McGill University on their latest articles published in Blood. The first half of the episode features "Anticoagulation with the mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933 A2 ) and cenvacibart (REGN7508 Cat )" during which Drs. Chalothorn and Gutstein discuss their research on anticoagulants targeting Factor XI and Factor XIa, which showed promising preclinical results in reducing thrombosis without increasing bleeding risk. They developed two distinct antibodies, targeting different domains of Factor 11, offering potential treatment options for different patient profiles. Next, while discussing "TGF-β–PDL1 signaling in neutrophils preserves the lung barrier during hyperinflammation", Dr. Thanabalasuriar underscores that dissecting neutrophil-specific TGF‑β/PD‑L1 signaling in real ICU patients is essential to translate this pathway into truly personalized therapies that both preserve lung barrier integrity and prevent fatal hyperinflammatory injury.
- Oct 1, 202616 min
Designing Durable Remissions in Relapsed AML and Follicular Lymphoma
In this week's episode, Blood editor Dr. Laura Michaelis interviews Dr. Harry Erba of Duke University and Dr. Sairah Ahmed of the University of Texas MD Anderson Cancer Center on their latest articles published in Blood on durable treatment strategies for relapsed and refractory hematologic malignancies. Dr. Erba discusses "Ziftomenib with venetoclax and azacitidine for relapsed/refractory NPM1-mutated acute myeloid leukemia" highlighting the promise of this triplet regimen in a high-risk relapsed setting and delving into the mechanistic differences among menin inhibitors. Dr. Ahmed discusses "Durable efficacy and manageable long-term safety of lisocabtagene maraleucel for 3L+ FL: 3-year update from TRANSCEND FL" reviewing the 94% complete response rate, long-term safety profile, and how clinicians can decide whether a patient with relapsed follicular lymphoma is better suited for a bispecific antibody or CAR T-cell therapy.
- Sep 24, 202614 min
Dose Makes the Cure: Venetoclax in Ph- ALL
In this week's episode, Blood editor Dr. James Griffin interviews Dr. Jianxiang Wang from the National Clinical Research Center for Blood Diseases and the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College in Tianjin, China, on his latest article published in Blood titled "Venetoclax plus pediatric regimen in adolescents and adults with Ph-negative acute lymphoblastic leukemia." In this prospective phase 2 study, 167 adolescents and adults (aged 14-60 years) with ND Ph− ALL received a course of venetoclax combined with pediatric-inspired chemotherapy, to determine the results of this treatment on MRD negativity.
- Sep 17, 202630 min
Exploiting Vulnerabilities in High‑Risk MM and Mapping the Red Cell Interactome
In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Mariateresa Fulciniti and Angelo D'Alessandro on their latest articles published in Blood. Dr. Fulciniti, of the Dana Farber Cancer Institute, discusses the development of "PKMYT1 is a targetable vulnerability in del(17p) high-risk multiple myeloma" starting from the question, "Is 17P loss simply a prognostic marker, or does it create specific vulnerabilities that we can therapeutically exploit?" Then, Dr. D'Alessandro, of the University of Colorado, discusses "The red blood cell proteome and interactome identify a Band 3–BLVRB axis regulating hypoxic metabolic adaptation." His team began by asking, "What's in a red blood cell? How many proteins are there, and how can we confidently claim that these now several 1000s of proteins in opposite excess are indeed proteins within red blood cells are not coming from contaminants?" Both studies describe how deep molecular profiling can uncover specific, potentially targetable biological dependencies or interaction axes that may enable more precise, mechanism‑based therapeutic strategies.
Get Blood Podcast summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
The Internet Book of Critical Care Podcast
A podcast exploring critical care medicine through chapter discussions and evidence-based updates from The Internet Book of Critical Care.
Red Pill Your Healthcast
Two healthcare providers discuss overlooked health issues and empower listeners to make informed decisions for their families.
The Genomics Lab
Olivia Grant
Frankly Speaking About Family Medicine
Discusses current topics and developments in primary care and family medicine.
Pathogen Perspectives
pathogenperspectives
A Shot in the Arm Podcast
Ben Plumley
The VPZD Show
Two physicians discuss healthcare, medicine, and policy from a contrarian, middle-ground perspective.
The Curbsiders Internal Medicine Podcast
Expert-led internal medicine discussions with clinical insights and humor for primary care and hospital medicine providers.
This Podcast Will Kill You
Two epidemiologists explore the science, history, and impact of diseases and medical mysteries, one deadly topic at a time.
Science Magazine Podcast
Weekly episodes covering original scientific research, global science news, and expert commentary.
ICU Ed and Todd-Cast
Eddie and Todd
DR. GUNDRY PODCAST: GUT HEALTH, WEIGHT LOSS, AND NUTRITION
Explores gut health, nutrition, and chronic illness through the lens of plant-based diets, lectin avoidance, and microbiome science.
About Blood Podcast
Stay up to date on the latest research and reviews for both clinical and basic hematology with Blood podcast, published weekly in conjunction with each issue of Blood. Additionally, Blood review series podcasts feature in depth discussion with authors of recently published review articles.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Blood Podcast in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Blood Podcast daily summary?
It's a free AI-powered email that summarizes new episodes of Blood Podcast as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Blood Podcast podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Blood Podcast product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by American Society of Hematology.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does Blood Podcast release new episodes?
Blood Podcast publishes weekly. Our AI generates a summary within hours of each new episode.
What topics does Blood Podcast cover?
Blood Podcast covers topics including Science, Medicine, Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Blood Podcast summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.